Clinical trialPhase 1 / Phase 2Terminated
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
- Outcome
- Stopped earlyPI not longer at site. (Other)
- Phase
- Phase 1 / Phase 2
- Status
- Terminated
- Study type
- Interventional
- Start
- December 2014
- Expected end
- January 2018
- Enrollment
- 81 participants
- Sites
- 2
- Primary outcomes
- Determine the recommended phase 2 dose
- Sponsor
- Other
- Results posted
- No
- Last update
- 2 July 2018
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try